

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 7.99220406 |
| 2 | cytidine catabolic process (GO:0006216) | 7.99220406 |
| 3 | cytidine deamination (GO:0009972) | 7.99220406 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.07288618 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.76879676 |
| 6 | eosinophil chemotaxis (GO:0048245) | 6.53933147 |
| 7 | DNA deamination (GO:0045006) | 6.51323172 |
| 8 | positive regulation of monocyte chemotaxis (GO:0090026) | 6.25888748 |
| 9 | negative regulation by host of viral transcription (GO:0043922) | 6.18836628 |
| 10 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 6.15393642 |
| 11 | regulation of activation of Janus kinase activity (GO:0010533) | 6.01161064 |
| 12 | eosinophil migration (GO:0072677) | 6.00175060 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.99340068 |
| 14 | T cell migration (GO:0072678) | 5.96751745 |
| 15 | positive thymic T cell selection (GO:0045059) | 5.73986015 |
| 16 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.73597001 |
| 17 | positive T cell selection (GO:0043368) | 5.59664750 |
| 18 | response to interleukin-15 (GO:0070672) | 5.54508891 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 5.48206825 |
| 20 | positive regulation of interleukin-8 secretion (GO:2000484) | 5.44507354 |
| 21 | positive regulation of T cell chemotaxis (GO:0010820) | 5.43279559 |
| 22 | regulation of T cell chemotaxis (GO:0010819) | 5.43279559 |
| 23 | regulation of regulatory T cell differentiation (GO:0045589) | 5.24912459 |
| 24 | negative regulation of T cell apoptotic process (GO:0070233) | 5.24534503 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.22112946 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.75802299 |
| 27 | regulation of chronic inflammatory response (GO:0002676) | 4.75340017 |
| 28 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.69661970 |
| 29 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.57854740 |
| 30 | positive regulation of lymphocyte migration (GO:2000403) | 4.57504382 |
| 31 | macrophage chemotaxis (GO:0048246) | 4.46996328 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.40568204 |
| 33 | dendritic cell chemotaxis (GO:0002407) | 4.27032690 |
| 34 | regulation of monocyte chemotaxis (GO:0090025) | 4.25168399 |
| 35 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.22508379 |
| 36 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.15215171 |
| 37 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.15215171 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09143883 |
| 39 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.03632545 |
| 40 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 4.01928065 |
| 41 | positive regulation of translational initiation (GO:0045948) | 3.99029379 |
| 42 | negative T cell selection (GO:0043383) | 3.93406827 |
| 43 | regulation of interleukin-8 secretion (GO:2000482) | 3.91562865 |
| 44 | regulation of macrophage chemotaxis (GO:0010758) | 3.89584451 |
| 45 | regulation of mononuclear cell migration (GO:0071675) | 3.88310232 |
| 46 | membrane raft organization (GO:0031579) | 3.84350519 |
| 47 | lymphocyte chemotaxis (GO:0048247) | 3.83336840 |
| 48 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.82981836 |
| 49 | protein neddylation (GO:0045116) | 3.82825394 |
| 50 | thymic T cell selection (GO:0045061) | 3.82518356 |
| 51 | natural killer cell activation (GO:0030101) | 3.80897561 |
| 52 | T cell selection (GO:0045058) | 3.77214915 |
| 53 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.76436461 |
| 54 | cytolysis (GO:0019835) | 3.76348384 |
| 55 | granulocyte activation (GO:0036230) | 3.75798374 |
| 56 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.74414829 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74003198 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.72594824 |
| 59 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.72105761 |
| 60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.70023749 |
| 61 | cellular defense response (GO:0006968) | 3.68449964 |
| 62 | regulation of B cell differentiation (GO:0045577) | 3.68132425 |
| 63 | dendritic cell migration (GO:0036336) | 3.65915678 |
| 64 | positive regulation of T cell apoptotic process (GO:0070234) | 3.61922159 |
| 65 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.60549171 |
| 66 | regulation of lymphocyte migration (GO:2000401) | 3.59681225 |
| 67 | positive regulation of T cell migration (GO:2000406) | 3.58480495 |
| 68 | chemokine-mediated signaling pathway (GO:0070098) | 3.57882477 |
| 69 | localization within membrane (GO:0051668) | 3.53763528 |
| 70 | lymphocyte migration (GO:0072676) | 3.53060478 |
| 71 | negative regulation of viral transcription (GO:0032897) | 3.52052379 |
| 72 | positive regulation of tolerance induction (GO:0002645) | 3.51105558 |
| 73 | lymph node development (GO:0048535) | 3.48655746 |
| 74 | adaptation of signaling pathway (GO:0023058) | 3.48252755 |
| 75 | DNA demethylation (GO:0080111) | 3.47943080 |
| 76 | diterpenoid biosynthetic process (GO:0016102) | 3.47645211 |
| 77 | T cell costimulation (GO:0031295) | 3.46922269 |
| 78 | monocyte chemotaxis (GO:0002548) | 3.45542193 |
| 79 | lymphocyte costimulation (GO:0031294) | 3.42536951 |
| 80 | negative regulation of viral genome replication (GO:0045071) | 3.41080622 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.36356281 |
| 82 | positive regulation of cell killing (GO:0031343) | 3.33529250 |
| 83 | negative regulation of B cell proliferation (GO:0030889) | 3.33480597 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 3.31750435 |
| 85 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.31713652 |
| 86 | T cell receptor signaling pathway (GO:0050852) | 3.31647745 |
| 87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.28931570 |
| 88 | regulation of T cell apoptotic process (GO:0070232) | 3.27978318 |
| 89 | regulation of calcium-mediated signaling (GO:0050848) | 3.26870854 |
| 90 | modulation by host of symbiont transcription (GO:0052472) | 3.25117707 |
| 91 | modulation by host of viral transcription (GO:0043921) | 3.25117707 |
| 92 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.23969200 |
| 93 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.22387349 |
| 94 | T cell mediated immunity (GO:0002456) | 3.20942962 |
| 95 | positive regulation of macrophage differentiation (GO:0045651) | 3.19859462 |
| 96 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19419660 |
| 97 | negative regulation of T cell activation (GO:0050868) | 3.19230546 |
| 98 | hepatocyte apoptotic process (GO:0097284) | 3.18202920 |
| 99 | signal peptide processing (GO:0006465) | 3.18167213 |
| 100 | regulation of T cell migration (GO:2000404) | 3.17638685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.82231994 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.49083793 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.40447593 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.33289785 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.30365397 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08298605 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.24031323 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.09666981 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.91744689 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.90684697 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90557981 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69923368 |
| 13 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.59813383 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56949541 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.44815186 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36508095 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.33788452 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24970654 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.23256050 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11895569 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09589146 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.8958237 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.98849359 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.87446880 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85681306 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85551926 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84221780 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83814066 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77415759 |
| 30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.76896853 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64272218 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59802604 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45093696 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.42171664 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38061889 |
| 36 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.36929034 |
| 37 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32375114 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29965529 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29036793 |
| 40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23466602 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21930222 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21602738 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20454355 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19097332 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17134787 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12873277 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12044918 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08092957 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07151911 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04517673 |
| 51 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03337943 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02603625 |
| 53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00908532 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98280856 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98083053 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97265885 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96949502 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96758489 |
| 59 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96648347 |
| 60 | GATA3_26560356_Chip-Seq_TH1_Human | 0.96373053 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94712589 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94391587 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91468724 |
| 64 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91433668 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91354548 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89039757 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85510993 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84953165 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83807634 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83444152 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78982868 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78473643 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78236665 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77846596 |
| 75 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77844202 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.75598817 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74404668 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74119332 |
| 79 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73123116 |
| 80 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.71423758 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71131138 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 0.70505729 |
| 83 | P300_27268052_Chip-Seq_Bcells_Human | 0.67998856 |
| 84 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.67552787 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.66298928 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66202596 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.66050276 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65502141 |
| 89 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.65493129 |
| 90 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.65295987 |
| 91 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.64522649 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.62374408 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.62080485 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61606404 |
| 95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.61508532 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61037416 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.60963081 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.58601924 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 0.58221129 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.58109287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.46593370 |
| 2 | MP0009785_altered_susceptibility_to | 4.24688267 |
| 3 | MP0003866_abnormal_defecation | 3.79889556 |
| 4 | MP0006082_CNS_inflammation | 3.33423111 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.18068133 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.12357907 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.10342146 |
| 8 | MP0005025_abnormal_response_to | 2.98883923 |
| 9 | MP0001800_abnormal_humoral_immune | 2.93894042 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.75694749 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.68756539 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.68396982 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.66717312 |
| 14 | MP0001819_abnormal_immune_cell | 2.65377173 |
| 15 | MP0002723_abnormal_immune_serum | 2.54941451 |
| 16 | MP0002405_respiratory_system_inflammati | 2.45480240 |
| 17 | MP0002398_abnormal_bone_marrow | 2.30342815 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.20143354 |
| 19 | MP0003448_altered_tumor_morphology | 2.15812735 |
| 20 | MP0000716_abnormal_immune_system | 2.15573437 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.14889924 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.12501006 |
| 23 | MP0003436_decreased_susceptibility_to | 2.12290207 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.07883131 |
| 25 | MP0002419_abnormal_innate_immunity | 2.05852360 |
| 26 | MP0001790_abnormal_immune_system | 1.97340795 |
| 27 | MP0005387_immune_system_phenotype | 1.97340795 |
| 28 | MP0002722_abnormal_immune_system | 1.95569098 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.89265641 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.86561875 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.85071806 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.82573278 |
| 33 | MP0002429_abnormal_blood_cell | 1.75187091 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.62086390 |
| 35 | MP0003724_increased_susceptibility_to | 1.58786269 |
| 36 | MP0000685_abnormal_immune_system | 1.58117540 |
| 37 | MP0002006_tumorigenesis | 1.56435548 |
| 38 | MP0003045_fibrosis | 1.55688442 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.48502302 |
| 40 | MP0003878_abnormal_ear_physiology | 1.43288379 |
| 41 | MP0005377_hearing/vestibular/ear_phenot | 1.43288379 |
| 42 | MP0003011_delayed_dark_adaptation | 1.42937077 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.42022653 |
| 44 | MP0001873_stomach_inflammation | 1.40472178 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.39728045 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.38358273 |
| 47 | MP0001853_heart_inflammation | 1.33452528 |
| 48 | MP0008469_abnormal_protein_level | 1.30488739 |
| 49 | MP0004947_skin_inflammation | 1.30419213 |
| 50 | MP0005310_abnormal_salivary_gland | 1.27978686 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.20415452 |
| 52 | MP0002933_joint_inflammation | 1.18244380 |
| 53 | MP0009763_increased_sensitivity_to | 1.14579955 |
| 54 | MP0004381_abnormal_hair_follicle | 1.14254051 |
| 55 | MP0010307_abnormal_tumor_latency | 1.09927815 |
| 56 | MP0002095_abnormal_skin_pigmentation | 1.08205961 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 1.06611934 |
| 58 | MP0004130_abnormal_muscle_cell | 1.05963669 |
| 59 | MP0005166_decreased_susceptibility_to | 1.03066600 |
| 60 | MP0000858_altered_metastatic_potential | 1.02206945 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.01966307 |
| 62 | MP0008260_abnormal_autophagy | 0.99988970 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.99075421 |
| 64 | MP0002132_abnormal_respiratory_system | 0.98059753 |
| 65 | MP0005058_abnormal_lysosome_morphology | 0.94679147 |
| 66 | MP0001661_extended_life_span | 0.93005247 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.90690873 |
| 68 | MP0005670_abnormal_white_adipose | 0.88676525 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 0.86770461 |
| 70 | MP0009764_decreased_sensitivity_to | 0.85043617 |
| 71 | MP0004134_abnormal_chest_morphology | 0.84968711 |
| 72 | MP0002163_abnormal_gland_morphology | 0.81583940 |
| 73 | MP0006054_spinal_hemorrhage | 0.81484060 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.78533803 |
| 75 | MP0000343_altered_response_to | 0.73907315 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.73497415 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.72718969 |
| 78 | MP0008873_increased_physiological_sensi | 0.71826580 |
| 79 | MP0003137_abnormal_impulse_conducting | 0.70141964 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.67927824 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.67672891 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.67408112 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.60863023 |
| 84 | MP0001533_abnormal_skeleton_physiology | 0.59571714 |
| 85 | MP0003786_premature_aging | 0.56738711 |
| 86 | MP0003943_abnormal_hepatobiliary_system | 0.56050473 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.55863201 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.55755476 |
| 89 | MP0003690_abnormal_glial_cell | 0.55631494 |
| 90 | MP0002009_preneoplasia | 0.54864112 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.53929214 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.53215931 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.50853436 |
| 94 | MP0004883_abnormal_blood_vessel | 0.50607572 |
| 95 | MP0000920_abnormal_myelination | 0.49812114 |
| 96 | MP0001188_hyperpigmentation | 0.48721240 |
| 97 | MP0008770_decreased_survivor_rate | 0.48657804 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.44658960 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.44317716 |
| 100 | MP0000490_abnormal_crypts_of | 0.43004444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.61631438 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.04122516 |
| 3 | Abnormality of T cells (HP:0002843) | 5.71416870 |
| 4 | Chronic diarrhea (HP:0002028) | 5.23244081 |
| 5 | Aplastic anemia (HP:0001915) | 4.86675751 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.65482091 |
| 7 | Autoimmune hemolytic anemia (HP:0001890) | 4.46234175 |
| 8 | Hypoproteinemia (HP:0003075) | 4.03243379 |
| 9 | Abnormality of T cell physiology (HP:0011840) | 3.78015962 |
| 10 | Recurrent viral infections (HP:0004429) | 3.76515268 |
| 11 | Meningitis (HP:0001287) | 3.75177068 |
| 12 | Abnormality of the prostate (HP:0008775) | 3.74947645 |
| 13 | IgG deficiency (HP:0004315) | 3.70718709 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.60683554 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.57784752 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.57740524 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.56746788 |
| 18 | J-shaped sella turcica (HP:0002680) | 3.55867255 |
| 19 | Lymphopenia (HP:0001888) | 3.50761694 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.32793480 |
| 21 | Pustule (HP:0200039) | 3.29560341 |
| 22 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.29354017 |
| 23 | Obstructive lung disease (HP:0006536) | 3.24468816 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24468816 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.20529926 |
| 26 | Recurrent bronchitis (HP:0002837) | 3.20124994 |
| 27 | Stomatitis (HP:0010280) | 3.19961760 |
| 28 | Hemoptysis (HP:0002105) | 3.18183430 |
| 29 | Abnormal biliary tract physiology (HP:0012439) | 3.11670081 |
| 30 | Bile duct proliferation (HP:0001408) | 3.11670081 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.11497675 |
| 32 | Joint swelling (HP:0001386) | 3.11069433 |
| 33 | Recurrent abscess formation (HP:0002722) | 3.06237825 |
| 34 | Chest pain (HP:0100749) | 3.05657427 |
| 35 | Gangrene (HP:0100758) | 3.03459908 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01319031 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01319031 |
| 38 | IgM deficiency (HP:0002850) | 2.92788764 |
| 39 | Myositis (HP:0100614) | 2.92154875 |
| 40 | Vasculitis (HP:0002633) | 2.90910150 |
| 41 | Encephalitis (HP:0002383) | 2.88188369 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.87562881 |
| 43 | Increased IgM level (HP:0003496) | 2.84153783 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.76408045 |
| 45 | Ureteral stenosis (HP:0000071) | 2.75333921 |
| 46 | Severe visual impairment (HP:0001141) | 2.73515802 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.72601719 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.70610493 |
| 49 | Optic neuritis (HP:0100653) | 2.70610493 |
| 50 | Abnormality of the alveolar ridges (HP:0006477) | 2.70024486 |
| 51 | Carpal bone hypoplasia (HP:0001498) | 2.64682565 |
| 52 | Recurrent skin infections (HP:0001581) | 2.61287085 |
| 53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.60092233 |
| 54 | Bronchitis (HP:0012387) | 2.59765122 |
| 55 | Hemiplegia (HP:0002301) | 2.55721550 |
| 56 | Ureteral obstruction (HP:0006000) | 2.51852703 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50578255 |
| 58 | Combined immunodeficiency (HP:0005387) | 2.47848014 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.45669865 |
| 60 | IgA deficiency (HP:0002720) | 2.45418514 |
| 61 | Thyroiditis (HP:0100646) | 2.43755543 |
| 62 | Eosinophilia (HP:0001880) | 2.43700962 |
| 63 | Amaurosis fugax (HP:0100576) | 2.43507178 |
| 64 | Leukocytosis (HP:0001974) | 2.42650271 |
| 65 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.38182179 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.38182179 |
| 67 | Abnormality of oral frenula (HP:0000190) | 2.35379878 |
| 68 | Granulocytopenia (HP:0001913) | 2.34554898 |
| 69 | Recurrent otitis media (HP:0000403) | 2.33801175 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.33418899 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.30261024 |
| 72 | Pulmonary embolism (HP:0002204) | 2.30137637 |
| 73 | Orchitis (HP:0100796) | 2.28683169 |
| 74 | Zonular cataract (HP:0010920) | 2.26687499 |
| 75 | Poor speech (HP:0002465) | 2.26276152 |
| 76 | Acute hepatic failure (HP:0006554) | 2.26161808 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.24793947 |
| 78 | Hypoplasia of the thymus (HP:0000778) | 2.21746092 |
| 79 | Lymphoma (HP:0002665) | 2.19319303 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.18906352 |
| 81 | Stomach cancer (HP:0012126) | 2.18877120 |
| 82 | Anorexia (HP:0002039) | 2.17489529 |
| 83 | B lymphocytopenia (HP:0010976) | 2.17135555 |
| 84 | True hermaphroditism (HP:0010459) | 2.16052880 |
| 85 | Renal cortical cysts (HP:0000803) | 2.15037305 |
| 86 | Broad face (HP:0000283) | 2.13001835 |
| 87 | Pulmonary fibrosis (HP:0002206) | 2.09785226 |
| 88 | Arterial thrombosis (HP:0004420) | 2.09633972 |
| 89 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.08384046 |
| 90 | Epistaxis (HP:0000421) | 2.07671854 |
| 91 | Pancreatic cysts (HP:0001737) | 2.05167281 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.03540955 |
| 93 | Abnormality of male internal genitalia (HP:0000022) | 2.02497601 |
| 94 | Congenital stationary night blindness (HP:0007642) | 1.99098423 |
| 95 | Hypoalbuminemia (HP:0003073) | 1.97960167 |
| 96 | Abnormal albumin level (HP:0012116) | 1.97960167 |
| 97 | Neurodegeneration (HP:0002180) | 1.93966207 |
| 98 | Hematochezia (HP:0002573) | 1.93715928 |
| 99 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92272719 |
| 100 | Abnormality of binocular vision (HP:0011514) | 1.90552285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.02862571 |
| 2 | KDR | 4.25856364 |
| 3 | FES | 3.52556356 |
| 4 | ITK | 3.50509275 |
| 5 | GRK7 | 3.32958238 |
| 6 | EIF2AK3 | 3.20727954 |
| 7 | TRIM28 | 2.64533439 |
| 8 | ZAK | 2.56429063 |
| 9 | BCKDK | 2.18073192 |
| 10 | TGFBR2 | 2.16108089 |
| 11 | JAK3 | 1.98767975 |
| 12 | SYK | 1.97085856 |
| 13 | MAP4K1 | 1.96917891 |
| 14 | TEC | 1.95134780 |
| 15 | MOS | 1.88957460 |
| 16 | ZAP70 | 1.84286697 |
| 17 | PRKCQ | 1.74248782 |
| 18 | BTK | 1.62701718 |
| 19 | CSK | 1.61634894 |
| 20 | STK16 | 1.58274991 |
| 21 | LCK | 1.50222858 |
| 22 | PIK3CG | 1.47270316 |
| 23 | STK10 | 1.41920723 |
| 24 | TAF1 | 1.39817639 |
| 25 | RIPK4 | 1.38966543 |
| 26 | MELK | 1.28702049 |
| 27 | MAP2K6 | 1.26935146 |
| 28 | TAOK3 | 1.25442811 |
| 29 | LYN | 1.24200906 |
| 30 | KIT | 1.23908400 |
| 31 | WNK4 | 1.17350781 |
| 32 | JAK2 | 1.16293957 |
| 33 | MST4 | 1.11479954 |
| 34 | CLK1 | 1.09588819 |
| 35 | PIK3CA | 1.08674682 |
| 36 | PDK1 | 1.05303524 |
| 37 | MAP3K12 | 1.05176312 |
| 38 | CSF1R | 1.00926918 |
| 39 | TESK2 | 0.95326413 |
| 40 | GRK5 | 0.92973842 |
| 41 | TBK1 | 0.92944796 |
| 42 | HCK | 0.92537731 |
| 43 | BUB1 | 0.89965911 |
| 44 | MAPKAPK3 | 0.88168727 |
| 45 | ADRBK2 | 0.86813264 |
| 46 | FYN | 0.85412736 |
| 47 | EIF2AK2 | 0.82917564 |
| 48 | JAK1 | 0.81253090 |
| 49 | BLK | 0.80557832 |
| 50 | IGF1R | 0.80039372 |
| 51 | PDK2 | 0.77677692 |
| 52 | MAPK15 | 0.74203746 |
| 53 | GRK1 | 0.72524686 |
| 54 | DAPK1 | 0.70255380 |
| 55 | FGR | 0.65350773 |
| 56 | EIF2AK1 | 0.61545809 |
| 57 | PRKCH | 0.60075327 |
| 58 | GRK6 | 0.55880198 |
| 59 | WNK1 | 0.53155335 |
| 60 | FRK | 0.50856475 |
| 61 | MATK | 0.49468156 |
| 62 | TIE1 | 0.48821786 |
| 63 | INSR | 0.48742474 |
| 64 | NEK6 | 0.45543410 |
| 65 | OXSR1 | 0.45445906 |
| 66 | MYLK | 0.45438957 |
| 67 | FLT3 | 0.44594576 |
| 68 | IRAK4 | 0.42871521 |
| 69 | TRPM7 | 0.41416583 |
| 70 | MAPKAPK2 | 0.40177084 |
| 71 | PIM1 | 0.39688306 |
| 72 | MAPK11 | 0.38838216 |
| 73 | IKBKE | 0.38126489 |
| 74 | TNK2 | 0.37037269 |
| 75 | MAPK3 | 0.37010441 |
| 76 | DAPK2 | 0.34134080 |
| 77 | TLK1 | 0.33573773 |
| 78 | ABL1 | 0.33349915 |
| 79 | IKBKB | 0.32831842 |
| 80 | CDK19 | 0.32729404 |
| 81 | RPS6KA5 | 0.32646361 |
| 82 | TYK2 | 0.32138644 |
| 83 | GSK3A | 0.30257381 |
| 84 | PRKCA | 0.28803971 |
| 85 | CDK6 | 0.28548989 |
| 86 | NTRK2 | 0.28292696 |
| 87 | ROCK1 | 0.27858532 |
| 88 | PDPK1 | 0.27745233 |
| 89 | MARK3 | 0.25977625 |
| 90 | MAP3K5 | 0.23304461 |
| 91 | STK11 | 0.22715455 |
| 92 | CDK4 | 0.20759720 |
| 93 | ADRBK1 | 0.20464372 |
| 94 | PDGFRB | 0.19176619 |
| 95 | VRK1 | 0.18116523 |
| 96 | IRAK1 | 0.16987851 |
| 97 | PRKCB | 0.16258139 |
| 98 | ACVR1B | 0.14932836 |
| 99 | PAK1 | 0.14907208 |
| 100 | SGK1 | 0.14405616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.29177634 |
| 2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.76437323 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.71056630 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.51271846 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.25040618 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.18877194 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.03356979 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.90897602 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.64277098 |
| 10 | Salmonella infection_Homo sapiens_hsa05132 | 2.63449004 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.44621175 |
| 12 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.32893613 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19059788 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15441428 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.04679066 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.03211239 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.86296587 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.85863671 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.72088710 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.39932127 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35265256 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.34268885 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30217042 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28705167 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.22908135 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.18347298 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17520717 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15034986 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06692136 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.06667641 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.00454181 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98613718 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97875824 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96430253 |
| 35 | Asthma_Homo sapiens_hsa05310 | 0.93566505 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92942227 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91955451 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88940811 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87759487 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 0.86897706 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 0.82398310 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81302427 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78582675 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75917681 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74898655 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.72932500 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72470853 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72135705 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72102422 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72021546 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67770042 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63653969 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63340948 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61315359 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60160125 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.59514444 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.56748488 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55883993 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55009814 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52524491 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51374883 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50570055 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49757645 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48787776 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47455747 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47126726 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.45796375 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.41549165 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.39014657 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38502990 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.34459036 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33514776 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.31352484 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.30888490 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.30495078 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30385313 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29070275 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25939197 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.25356979 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24522747 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23714796 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22689051 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22392406 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.21307119 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.19225786 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.18993507 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17345559 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16310399 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15971633 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.15647598 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14817000 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.12222782 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09521406 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.08832584 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08534746 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07578427 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07027662 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.06280234 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05595997 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05533539 |

